Novo Nordisk’s Wegovy approved to treat liver disease in US
Wegovy gets green light for liver disease More than 22 million affected in US First GLP-1 drug to get approval Danish healthcare giant Novo Nordisk (NOVO-B:CPH) rallied as much as 6% after it's blockbuster weight loss drug Wegovy...
18 August 2025